5 results match your criteria: "Magrabi Hospitals and Centers[Affiliation]"
Clin Ophthalmol
January 2025
Magrabi Hospitals and Centers, Riyadh, Saudi Arabia.
Aim: This systematic review and meta-analysis aimed to evaluate the safety and efficacy of combined laser and anti-VEGF therapy for (retinopathy of prematurity ROP), focusing on both structural and functional outcomes.
Methods: A comprehensive search was conducted in multiple databases to identify randomized controlled trials (RCTs) that investigated combination therapy for ROP. The PRISMA guidelines were followed.
Int Ophthalmol
December 2023
Ingenieurbüro Pieger GmbH, Wendelstein, Germany.
Purpose: To use spectral-domain optical coherence tomography (SD-OCT) data to develop a new implantable collamer lens (ICL) sizing formula and compare vault outcomes with the Online Calculation and Ordering System™ (OCOS) and the NK2 formula.
Methods: Consecutive eyes (n = 237) were evaluated that had undergone ICL/toric ICL implantation. Actual ICL vaults were measured, and a what-if analysis was performed to predict vault values with the NK2 formula using SD-OCT data.
Int Ophthalmol
October 2023
Magrabi Hospitals and Centers, Main Jeddah Hospital, Old Makkah Rd. K3, Khozam St., PO Box: 7344, Jeddah, 21462, Saudi Arabia.
Purpose: To evaluate the efficacy and safety of transepithelial accelerated crosslinking (TE-ACXL) using pulsed light and supplemental oxygen.
Methods: Thirty eyes of 30 consecutive patients with progressive keratoconus or post-LASIK ectasia were enrolled in a prospective non-comparative study conducted at the Magrabi Eye Center (Jeddah, Saudi Arabia). All eyes underwent TE-ACXL with supplemental oxygen.
Int Ophthalmol
May 2021
Glaucoma and Cataract Unit, Magrabi Hospitals and Centers, Mascat, Oman.
Purpose: To study midterm efficacy and safety of combined Visco-Trab operation for management of advanced glaucoma.
Methods: 168 eyes of 148 patients with advanced glaucoma had Visco-Trab operation (a merge of both viscocanalostomy and trabeculectomy operations). Mean follow-up was 29.
Saudi J Ophthalmol
October 2013
Chief Medical Officer Director, Cornea & Refractive Surgery Service, Magrabi Hospitals and Centers, Jeddah, Saudi Arabia.